Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-12-05 Sale | 2022-12-05 4:14 pm | SELLAS Life Sciences Group Inc. | SLS | Stergiou Angelos M. President and CEO | 6,494 | $2.6083 | $16,938 | 161,689 (Direct) | View |
| 2022-12-05 Sale | 2022-12-05 4:13 pm | SELLAS Life Sciences Group Inc. | SLS | Burns John Thomas Senior VP, Finance & CAO | 1,159 | $2.59 | $3,002 | 29,347 (Direct) | View |
| 2022-12-05 Sale | 2022-12-05 4:12 pm | SELLAS Life Sciences Group Inc. | SLS | WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec. | 2,153 | $2.59 | $5,576 | 56,344 (Direct) | View |
| 2021-12-02 Sale | 2021-12-03 5:15 pm | SELLAS Life Sciences Group Inc. | SLS | Stergiou Angelos M. President and CEO | 2,120 | $6.2509 | $13,252 | 121,167 (Direct) | View |
| 2021-12-02 Sale | 2021-12-03 5:14 pm | SELLAS Life Sciences Group Inc. | SLS | WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec. | 847 | $6.2547 | $5,298 | 42,028 (Direct) | View |
| 2021-12-02 Sale | 2021-12-03 5:13 pm | SELLAS Life Sciences Group Inc. | SLS | Burns John Thomas VP, Finance & Corp Controller | 231 | $6.2673 | $1,448 | 17,644 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-06 Other | 2023-12-08 4:11 pm | N/A N/A | SELLAS Life Sciences Group Inc. | SLS | WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec. | 4,119 | $1.08 | 86,344 (Direct) | View |
| 2023-12-06 Other | 2023-12-08 4:10 pm | N/A N/A | SELLAS Life Sciences Group Inc. | SLS | Stergiou Angelos M. President and CEO | 12,268 | $1.08 | 229,689 (Direct) | View |
| 2023-12-06 Other | 2023-12-08 4:10 pm | N/A N/A | SELLAS Life Sciences Group Inc. | SLS | Francomano Robert Chief Commercial Officer | 1,082 | $1.08 | 22,000 (Direct) | View |
| 2023-12-06 Other | 2023-12-08 4:10 pm | N/A N/A | SELLAS Life Sciences Group Inc. | SLS | Burns John Thomas CFO | 2,929 | $1.08 | 57,856 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-03 5:18 pm | N/A 2033-02-02 | SELLAS Life Sciences Group Inc. | SLS | WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec. | 100,000 | $0 | 156,344 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-03 5:17 pm | N/A 2033-02-02 | SELLAS Life Sciences Group Inc. | SLS | Burns John Thomas CFO | 95,000 | $0 | 124,347 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-03 5:15 pm | N/A 2033-02-02 | SELLAS Life Sciences Group Inc. | SLS | Stergiou Angelos M. President and CEO | 275,500 | $0 | 437,189 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-03 5:14 pm | N/A 2033-02-02 | SELLAS Life Sciences Group Inc. | SLS | Francomano Robert Chief Commercial Officer | 57,000 | $0 | 57,000 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-03 5:14 pm | N/A 2033-02-02 | SELLAS Life Sciences Group Inc. | SLS | Varian John Director | 12,000 | $0 | 13,900 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-03 5:13 pm | N/A 2033-02-02 | SELLAS Life Sciences Group Inc. | SLS | Wasman Jane Director | 12,000 | $0 | 13,900 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-03 5:11 pm | N/A 2033-02-02 | SELLAS Life Sciences Group Inc. | SLS | VAN NOSTRAND ROBERT L Director | 12,000 | $0 | 13,900 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-03 5:11 pm | N/A 2033-02-02 | SELLAS Life Sciences Group Inc. | SLS | SCHEINBERG DAVID A Director | 12,000 | $0 | 14,082 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-03 5:10 pm | N/A 2033-02-02 | SELLAS Life Sciences Group Inc. | SLS | Kalin Katherine Bach Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2022-08-13 Option Award | 2022-08-16 4:08 pm | N/A 2032-08-13 | SELLAS Life Sciences Group Inc. | SLS | Kalin Katherine Bach Director | 19,000 | $0 | 19,000 (Direct) | View |
Ownership | 2022-08-16 4:07 pm | N/A N/A | SELLAS Life Sciences Group Inc. | SLS | Kalin Katherine Bach Director | 0 | $0 | 0 (Direct) | View |
| 2022-03-14 Option Award | 2022-03-15 4:05 pm | N/A 2032-03-14 | SELLAS Life Sciences Group Inc. | SLS | Francomano Robert Chief Commercial Officer | 100,000 | $0 | 100,000 (Direct) | View |
Ownership | 2022-03-14 4:19 pm | N/A N/A | SELLAS Life Sciences Group Inc. | SLS | Francomano Robert Chief Commercial Officer | 0 | $0 | 0 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-01 5:07 pm | N/A 2032-01-31 | SELLAS Life Sciences Group Inc. | SLS | WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec. | 61,750 | $0 | 103,778 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-01 5:07 pm | N/A 2032-01-31 | SELLAS Life Sciences Group Inc. | SLS | Wasman Jane Director | 9,025 | $0 | 9,025 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-01 5:06 pm | N/A 2032-01-31 | SELLAS Life Sciences Group Inc. | SLS | Varian John Director | 9,025 | $0 | 9,025 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-01 5:06 pm | N/A 2032-01-31 | SELLAS Life Sciences Group Inc. | SLS | VAN NOSTRAND ROBERT L Director | 9,025 | $0 | 9,025 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-01 5:06 pm | N/A 2032-01-31 | SELLAS Life Sciences Group Inc. | SLS | Stergiou Angelos M. President and CEO | 209,000 | $0 | 330,167 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-01 5:05 pm | N/A 2032-01-31 | SELLAS Life Sciences Group Inc. | SLS | SCHEINBERG DAVID A Director | 9,025 | $0 | 9,207 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-01 5:05 pm | N/A 2032-01-31 | SELLAS Life Sciences Group Inc. | SLS | Burns John Thomas Senior VP, Finance & CAO | 45,600 | $0 | 63,244 (Direct) | View |
| 2021-03-04 Option Award | 2021-03-08 4:51 pm | N/A 2031-03-04 | SELLAS Life Sciences Group Inc. | SLS | WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec. | 55,125 | $0 | 80,125 (Direct) | View |
| 2021-03-04 Option Award | 2021-03-08 4:30 pm | N/A 2031-03-04 | SELLAS Life Sciences Group Inc. | SLS | SCHEINBERG DAVID A Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2021-03-04 Option Award | 2021-03-08 4:29 pm | N/A 2031-03-04 | SELLAS Life Sciences Group Inc. | SLS | Varian John Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2021-03-04 Option Award | 2021-03-08 4:29 pm | N/A 2031-03-04 | SELLAS Life Sciences Group Inc. | SLS | Wasman Jane Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2021-03-04 Option Award | 2021-03-08 4:28 pm | N/A 2031-03-04 | SELLAS Life Sciences Group Inc. | SLS | VAN NOSTRAND ROBERT L Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2021-03-04 Option Award | 2021-03-08 4:28 pm | N/A 2031-03-04 | SELLAS Life Sciences Group Inc. | SLS | Burns John Thomas VP, Finance & Corp Controller | 20,125 | $0 | 30,125 (Direct) | View |
| 2021-03-04 Option Award | 2021-03-08 4:26 pm | N/A 2031-03-04 | SELLAS Life Sciences Group Inc. | SLS | Stergiou Angelos M. President and CEO | 138,250 | $0 | 216,787 (Direct) | View |